Literature DB >> 185240

Chemotherapeutic compounds and Acanthamoebae from eye infections.

J Nagington, J E Richards.   

Abstract

The amoebicidal and amoebistatic action in vitro of 24 compounds was tested on two strains of Acanthamoeba, A. polyphaga and A. castellanii, isolated from eye infections in this country. For comparison, the Ryan strain of A. castellanii and Naegleria gruberi L-1 were also examined. Nine compounds showed sufficient activity to merit further consideration, ie, acriflavine, proflavine, hydroxystilbamidine isethionate, paromomycin, miconazole, amphoterin, neomycin, polymyxin, and the last two combined in Neosporin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 185240      PMCID: PMC476134          DOI: 10.1136/jcp.29.7.648

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  HARTMANELLA CASTELLANI (ACANTHAMOEBA SP): PRELIMINARY REPORT ON EXPERIMENTAL CHEMOTHERAPY.

Authors:  C G CULBERTSON; D H HOLMES; W M OVERTON
Journal:  Am J Clin Pathol       Date:  1965-04       Impact factor: 2.493

2.  Effect of clotrimazole on Naegleria fowleri.

Authors:  A Jamieson
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

Review 3.  Primary amoebic meningo-encephalitis. An appraisal of present knowledge.

Authors:  R F Carter
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

4.  Ryan virus: a possible new human pathogen.

Authors:  M S Pereira; H B Marsden; G Corbitt; J O Tobin
Journal:  Br Med J       Date:  1966-01-15

5.  Study of a small amoeba from mammalian cell cultures infected with 'Ryan virus'.

Authors:  D C Warhurst; J A Armstrong
Journal:  J Gen Microbiol       Date:  1968-02

6.  Amoebic infection of the eye.

Authors:  J Naginton; P G Watson; T J Playfair; J McGill; B R Jones; A D Steele
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

7.  Primary amoebic meningoencephalitis in Britain.

Authors:  J Apley; S K Clarke; A P Roome; S A Sandry; G Saygi; B Silk; D C Warhurst
Journal:  Br Med J       Date:  1970-03-07

8.  Sensitivity of Hartmannella (Acanthamoeba) to 5-fluorocytosine, hydroxystilbamidine, and other substances.

Authors:  D P Casemore
Journal:  J Clin Pathol       Date:  1970-11       Impact factor: 3.411

9.  Sensitivity to amphotericin B of a Naegleria sp. isolated from a case of primary amoebic meningoencephalitis.

Authors:  R F Carter
Journal:  J Clin Pathol       Date:  1969-07       Impact factor: 3.411

  9 in total
  17 in total

1.  Differentiation of Acanthamoeba strains from infected corneas and the environment by using restriction endonuclease digestion of whole-cell DNA.

Authors:  S Kilvington; J R Beeching; D G White
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

Review 2.  The Development of Drugs against Acanthamoeba Infections.

Authors:  Ruqaiyyah Siddiqui; Yousuf Aqeel; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

3.  Differentiation of Naegleria fowleri from Acanthamoeba species by using monoclonal antibodies and flow cytometry.

Authors:  B M Flores; C A Garcia; W E Stamm; B E Torian
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

4.  Susceptibility of Acanthamoeba castellanii to contact lens disinfecting solutions.

Authors:  S Zanetti; P L Fiori; A Pinna; S Usai; F Carta; G Fadda
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

5.  Acanthamoeba keratitis successfully treated medically.

Authors:  P Wright; D Warhurst; B R Jones
Journal:  Br J Ophthalmol       Date:  1985-10       Impact factor: 4.638

6.  Phenothiazine compounds inhibit in vitro growth of pathogenic free-living amoebae.

Authors:  F L Schuster; N Mandel
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

7.  Acanthamoebic keratitis diagnosed by paracentesis and biopsy and treated with propamidine.

Authors:  K McClellan; D J Coster
Journal:  Br J Ophthalmol       Date:  1987-10       Impact factor: 4.638

8.  Laboratory investigation of Acanthamoeba keratitis.

Authors:  S Kilvington; D F Larkin; D G White; J R Beeching
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

9.  A quantitative method to evaluate neutralizer toxicity against Acanthamoeba castellanii.

Authors:  S L Buck; R A Rosenthal
Journal:  Appl Environ Microbiol       Date:  1996-09       Impact factor: 4.792

10.  Acanthamoeba keratitis. A clinicopathological case report.

Authors:  M Hanssens; J F de Jonckheere; C de Meunynck
Journal:  Int Ophthalmol       Date:  1985-03       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.